| Richard C Archambault, EDD | |
|
593 Eddy St, Potter 3, Providence, RI 02903-4923 | |
| (401) 444-3534 | |
| (401) 444-3298 |
| Full Name | Richard C Archambault |
|---|---|
| Gender | Male |
| Speciality | Marriage & Family Therapist |
| Location | 593 Eddy St, Providence, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699750067 | NPI | - | NPPES |
| MFT00013 | Other | RI | PROFESSIONAL LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | MFT00013 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Richard C Archambault, EDD 593 Eddy St, Apc 978, Providence, RI 02903-4923 Ph: (401) 444-4318 | Richard C Archambault, EDD 593 Eddy St, Potter 3, Providence, RI 02903-4923 Ph: (401) 444-3534 |
News Archive
Today, the U.S. Food and Drug Administration approved the MiniMed 770G System, a hybrid closed loop diabetes management device that is intended to automatically monitor glucose (sugar) and provide appropriate basal insulin doses with little or no input from the users or their caregivers for use by individuals aged 2 to 6 with type 1 diabetes.
As health insurance moves to a direct-to-consumer model, identifying where consumers are located and what health plan options are available in local markets is essential. The Affordable Care Act is reshaping the industry and setting standards to ensure that consumers have coverage options in all geographies of every state in the U.S. Companies participating in the Marketplace (Exchanges) are using county market share and penetration rates to identify underinsured opportunities for Medicaid and Commercial market expansion.
Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved XALKORI (crizotinib) capsules, the first-ever therapy targeting anaplastic lymphoma kinase (ALK), for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) that is ALK-positive as detected by an FDA-approved test.
Yaping Tu, Ph.D., associate professor of pharmacology at Creighton University School of Medicine, has received a $450,000 Early Excellence Award from the American Asthma Foundation.
› Verified 5 days ago
Sandra Powers, LMHC Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 208 Governor St, Providence, RI 02906 Phone: 401-490-3563 Fax: 401-490-3563 | |
Elizabeth M Briggs, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 261 Wickenden St, Providence, RI 02903 Phone: 401-301-5638 | |
Paul C. Deffely, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 530 N Main St, Providence, RI 02904 Phone: 401-274-2500 | |
Ms. Amy Elizabeth Feucht Hogarth, MFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 198 Waterman St, Providence, RI 02906 Phone: 508-808-3910 | |
Marta Iachetta, M.ED., LMFT, CSAC Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 341 Broadway, Providence, RI 02909 Phone: 401-286-3741 | |
Mr. Bryan Mercier, MFT-A Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 55 Hope St, Providence, RI 02906 Phone: 401-331-1350 | |
Mr. Jason Domenic Dollard, MFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 178 Broadway, Providence, RI 02903 Phone: 401-525-6111 |